ZA201500203B - Transposition-mediated identification of specific binding or functional proteins - Google Patents

Transposition-mediated identification of specific binding or functional proteins

Info

Publication number
ZA201500203B
ZA201500203B ZA2015/00203A ZA201500203A ZA201500203B ZA 201500203 B ZA201500203 B ZA 201500203B ZA 2015/00203 A ZA2015/00203 A ZA 2015/00203A ZA 201500203 A ZA201500203 A ZA 201500203A ZA 201500203 B ZA201500203 B ZA 201500203B
Authority
ZA
South Africa
Prior art keywords
transposition
specific binding
functional proteins
mediated identification
mediated
Prior art date
Application number
ZA2015/00203A
Other languages
English (en)
Inventor
Grawunder Ulf
Original Assignee
Nbe-Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nbe-Therapeutics Llc filed Critical Nbe-Therapeutics Llc
Publication of ZA201500203B publication Critical patent/ZA201500203B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA2015/00203A 2012-07-18 2015-01-13 Transposition-mediated identification of specific binding or functional proteins ZA201500203B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261673144P 2012-07-18 2012-07-18
EP12178529.9A EP2692865B1 (en) 2012-07-30 2012-07-30 Transposition-mediated identification of specific binding or functional proteins
PCT/EP2013/065214 WO2014013026A1 (en) 2012-07-18 2013-07-18 Transposition-mediated identification of specific binding or functional proteins

Publications (1)

Publication Number Publication Date
ZA201500203B true ZA201500203B (en) 2015-12-23

Family

ID=49775745

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/00203A ZA201500203B (en) 2012-07-18 2015-01-13 Transposition-mediated identification of specific binding or functional proteins

Country Status (18)

Country Link
US (2) US10174309B2 (cg-RX-API-DMAC7.html)
EP (2) EP2692865B1 (cg-RX-API-DMAC7.html)
JP (1) JP6043431B2 (cg-RX-API-DMAC7.html)
CN (1) CN104640985B (cg-RX-API-DMAC7.html)
AU (1) AU2013291971B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015000836B1 (cg-RX-API-DMAC7.html)
CA (1) CA2878982C (cg-RX-API-DMAC7.html)
DK (1) DK2692865T3 (cg-RX-API-DMAC7.html)
ES (1) ES2528892T3 (cg-RX-API-DMAC7.html)
IL (1) IL236771A (cg-RX-API-DMAC7.html)
IN (1) IN2015DN01301A (cg-RX-API-DMAC7.html)
MX (1) MX338911B (cg-RX-API-DMAC7.html)
NZ (1) NZ705074A (cg-RX-API-DMAC7.html)
PT (1) PT2692865E (cg-RX-API-DMAC7.html)
SG (1) SG11201500280XA (cg-RX-API-DMAC7.html)
SI (1) SI2692865T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014013026A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201500203B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201407852D0 (en) 2014-05-02 2014-06-18 Iontas Ltd Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules
CA3001941A1 (en) 2015-10-30 2017-05-04 Nbe-Therapeutics Ag Anti-ror1 antibodies
CN109311982A (zh) 2016-01-20 2019-02-05 斯克利普斯研究所 Ror2抗体组合物和相关方法
MX2018008926A (es) 2016-01-20 2019-01-10 Scripps Research Inst Composiciones de anticuerpo contra ror1 y métodos relacionados.
JP2019513415A (ja) 2016-04-04 2019-05-30 イーティーエッチ チューリッヒ タンパク質産生及びライブラリー生成のための哺乳類細胞株
BR112019009495A2 (pt) 2016-12-09 2019-08-06 Gliknik Inc métodos de tratamento de distúrbios inflamatórios com compostos de fc multivalentes
BR112019009484A2 (pt) 2016-12-09 2019-07-30 Gliknik Inc otimização de fabricação de gl-2045, um stradomer multimerizador
US11278570B2 (en) 2016-12-16 2022-03-22 B-Mogen Biotechnologies, Inc. Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
CA3047313A1 (en) 2016-12-16 2018-06-21 B-Mogen Biotechnologies, Inc. Enhanced hat family transposon-mediated gene transfer and associated compositions, systems, and methods
US11447546B2 (en) 2017-07-20 2022-09-20 Nbe-Therapeutics Ag Human antibodies binding to ROR2
KR20230008269A (ko) 2017-08-07 2023-01-13 엔비이-테라퓨틱스 아게 생체 내 내성이 높은 항체 약물 결합체
WO2019219947A1 (en) * 2018-05-18 2019-11-21 Sorbonne Universite Molecular tools and methods for transgene integration and their transposition dependent expression
WO2019246486A2 (en) 2018-06-21 2019-12-26 B-Mogen Biotechnologies, Inc. ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
KR102559149B1 (ko) * 2018-10-26 2023-07-24 에프. 호프만-라 로슈 아게 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법
JP2020146014A (ja) * 2019-03-15 2020-09-17 株式会社東芝 トランスポゼース活性測定用ベクター、トランスポゼース活性測定用キット、トランスポゼース活性測定方法及び細胞分離方法
AU2020320910A1 (en) * 2019-07-30 2022-03-10 Akeso Biopharma, Inc. Anti-human p40 protein domain antibody and use thereof
WO2021046243A2 (en) 2019-09-03 2021-03-11 Myeloid Therapeutics, Inc. Methods and compositions for genomic integration
CN111139264B (zh) * 2020-01-20 2021-07-06 天津达济科技有限公司 一种基于线性双链dna分子在哺乳动物细胞系内构建单域抗体库的方法
KR102937659B1 (ko) 2020-02-19 2026-03-10 우시 바이올로직스 아일랜드 리미티드 강화된 발현 시스템 및 그 사용방법
MX2022012005A (es) * 2020-03-27 2022-10-21 Ddbio Co Ltd Shang Hai Metodo para el despliegue de anticuerpo biespecifico en la superficie de celula de mamifero y vector.
CN111471714A (zh) * 2020-05-07 2020-07-31 西南大学 Minos转座子系统介导的真核生物转基因细胞系及构建方法
CA3203531A1 (en) 2020-12-30 2022-07-07 Simon Olivares Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
JP2024507929A (ja) 2021-02-25 2024-02-21 アラウノス セラピューティクス インコーポレイテッド 多シストロン性発現カセットを含む組換えベクター及びそれらの使用方法
US20240360436A1 (en) * 2021-03-31 2024-10-31 DDBio. Co., Ltd. Vector and method for screening functional antigen-binding protein
WO2022241029A1 (en) 2021-05-11 2022-11-17 Myeloid Therapeutics, Inc. Methods and compositions for genomic integration
WO2023150562A1 (en) 2022-02-01 2023-08-10 Alaunos Therapeutics, Inc. Methods for activation and expansion of t cells
WO2024102954A1 (en) 2022-11-10 2024-05-16 Massachusetts Institute Of Technology Activation induced clipping system (aics)
WO2025158420A1 (en) 2024-01-25 2025-07-31 Nanocell Therapeutics Holdings B.V. Methods and composition for inducing activation and dna expression in t-cells
WO2025169168A1 (en) 2024-02-09 2025-08-14 Nanocell Therapeutics Holdings B.V. Extracorporeal transfection of immune effector cells
WO2025216732A1 (en) * 2024-04-10 2025-10-16 Duke University Methods and compositions relating to ecdna biogenesis
WO2025235862A1 (en) 2024-05-10 2025-11-13 Inndura Therapeutics Inc. A modified immune cell receptor comprising a target-binding domain and the extracellular domain of cd16a
WO2026159700A1 (en) 2025-01-27 2026-07-30 Nanocell Therapeutics Holdings B.V. Methods and composition for inducing activation and dna expression in t-cells

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5667988A (en) * 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US6218185B1 (en) 1996-04-19 2001-04-17 The United States Of America As Represented By The Secretary Of Agriculture Piggybac transposon-based genetic transformation system for insects
DK0973928T3 (da) 1997-03-11 2010-08-09 Univ Minnesota DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
US7160682B2 (en) 1998-11-13 2007-01-09 Regents Of The University Of Minnesota Nucleic acid transfer vector for the introduction of nucleic acid into the DNA of a cell
US7105343B1 (en) 2000-10-31 2006-09-12 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector Piggybac
US6962810B2 (en) 2000-10-31 2005-11-08 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
KR20040024560A (ko) 2001-06-14 2004-03-20 바스프 코포레이션 광안정화 잔기를 포함하는 광안정화 중합체, 그로부터제조된 물품 및 그의 제조방법
WO2003089618A2 (en) 2002-04-22 2003-10-30 Regents Of The University Of Minnesota Transposon system and methods of use
WO2003106639A2 (en) * 2002-06-14 2003-12-24 Dyax Corporation Recombination of nucleic acid library members
CA2492074A1 (en) 2002-07-10 2004-01-15 Stratagene Humanized renilla reniformis green fluorescent protein as a scaffold
ES2369542T3 (es) 2002-07-31 2011-12-01 Seattle Genetics, Inc. Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
US8071364B2 (en) * 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
US7932088B1 (en) 2005-04-25 2011-04-26 University Of Notre Dame Du Lac High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac
US20060252140A1 (en) 2005-04-29 2006-11-09 Yant Stephen R Development of a transposon system for site-specific DNA integration in mammalian cells
KR101323563B1 (ko) * 2005-10-18 2013-10-29 니토 보세키 가부시기가이샤 항체를 생산하는 트랜스제닉 누에와 그의 제조방법
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration
US9228180B2 (en) 2007-07-04 2016-01-05 Max-Delbruck-Centrum Fur Molekulare Medizin Polypeptide variants of sleeping beauty transposase
CA2698727A1 (en) 2007-09-17 2009-03-26 Affomix Corporation Increasing specificity in a scfv screen using dual bait reporters
US7863425B2 (en) * 2007-09-26 2011-01-04 Cornell University Compositions and methods for inhibiting Yersinia pestis infection
CN101903403B (zh) 2007-10-19 2016-03-16 西雅图基因公司 Cd19结合剂及其应用
EP2235181A1 (en) 2008-01-11 2010-10-06 MorphoSys AG Display vectors and methods and uses thereof
US9131671B2 (en) * 2008-02-01 2015-09-15 Entogenetics, Inc. Methods, compositions and systems for production of recombinant spider silk polypeptides
JP2009225781A (ja) * 2008-02-29 2009-10-08 Neosilk Co Ltd カイコを用いた糖鎖構造に特徴を有する糖蛋白質の製造方法
EP2098536A1 (en) * 2008-03-05 2009-09-09 4-Antibody AG Isolation and identification of antigen- or ligand-specific binding proteins
CN102245771B (zh) 2008-12-16 2013-04-10 诺瓦提斯公司 酵母展示系统
US20100311116A1 (en) * 2009-06-04 2010-12-09 Excellgene Sa Fast generation of high expression stable cell lines expressing recombinant proteins under minimal and short-term selective pressure
WO2012081628A1 (ja) 2010-12-15 2012-06-21 大学共同利用機関法人情報・システム研究機構 タンパク質の生産方法

Also Published As

Publication number Publication date
EP2692865A1 (en) 2014-02-05
PT2692865E (pt) 2015-02-06
ES2528892T3 (es) 2015-02-13
US20190153433A1 (en) 2019-05-23
AU2013291971B2 (en) 2016-02-04
JP2015522286A (ja) 2015-08-06
MX338911B (es) 2016-05-05
SI2692865T1 (sl) 2015-03-31
NZ705074A (en) 2017-04-28
BR112015000836B1 (pt) 2021-12-21
EP2692865B1 (en) 2014-12-10
EP2687599A1 (en) 2014-01-22
US10174309B2 (en) 2019-01-08
CA2878982A1 (en) 2014-01-23
HK1209779A1 (en) 2016-04-08
IL236771A (en) 2016-09-29
US20150152406A1 (en) 2015-06-04
CA2878982C (en) 2017-01-03
DK2692865T3 (en) 2015-02-16
SG11201500280XA (en) 2015-02-27
WO2014013026A1 (en) 2014-01-23
AU2013291971A1 (en) 2015-02-05
CN104640985B (zh) 2021-05-11
CN104640985A (zh) 2015-05-20
WO2014013026A8 (en) 2014-12-04
JP6043431B2 (ja) 2016-12-14
IN2015DN01301A (cg-RX-API-DMAC7.html) 2015-07-03
MX2015000885A (es) 2015-07-14
BR112015000836A2 (pt) 2017-12-12

Similar Documents

Publication Publication Date Title
SG11201500280XA (en) Transposition-mediated identification of specific binding or functional proteins
IL282226A (en) ST2 antigen-binding proteins
IL254652A0 (en) Unnatural albumin binding sites
ZA201504023B (en) Bcma antigen binding proteins
IL240838A0 (en) Anti-3–lag binding proteins
IL240915A0 (en) Dual-specific binding proteins directed against tnfɑ
AP2015008266A0 (en) 1L-18 binding molecules
IL233515A0 (en) Amino acids that specifically bind cgrp
IL239421A0 (en) Preparations and methods for the identification and isolation of groups of atoms that bind specifically to a protein in the cell membrane
EP2840960A4 (en) IDENTIFICATION OF VASCULAR TERRITORIES
GB201501101D0 (en) Isotopic labelling of proteins
PT2851083T (pt) Composição proteica resistente à esterilização por radiação
GB2499502B (en) Signature identification
GB201220418D0 (en) Identification of materials
GB201418608D0 (en) Peridinin-chlorophyll binding proteins
GB201220419D0 (en) Identification of materials
GB201213672D0 (en) Protein
GB201215901D0 (en) Protein modification
AP2012006467A0 (en) E-horn identification methods
GB201200743D0 (en) Protein bridges
GB201203944D0 (en) Binding polypeptides
AU2012901613A0 (en) Identification of vascular territories
AU349573S (en) Clip